Sophiris Bio, Inc. Gains 39.96%

Mon 06 Jan 20 at 05:30 PM
Sophiris Bio, Inc. Gains 39.96%

Sophiris Bio, Inc. (SPHS:NASDAQ) soared at $0.78, representing a gain of 40%. On Fri 03 Jan 20, SPHS:NASDAQ hit a New 2-Week High of $0.56. From Thu 12 Dec 19, the stock recorded 42.86% Up Days and 33.33% Green Days

About Sophiris Bio, Inc. (SPHS:NASDAQ)

Sophiris Bio Inc is a clinical-stage biopharmaceutical company. The Company is engaged in research and development of products for the treatment of urological diseases. It is currently developing PRX302 for treatment of benign prostatic hyperplasia.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.